ArticleOpen forum infectious diseases2025

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083.

Hannah P Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.